Highlights and cutting-edge advances in hepatobiliary and pancreatic cancer research at the American Society of Clinical Oncology (ASCO) Annual Meeting 2025

Abstract:

The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting was held in Chicago from May 30 to June 3, 2025. As one of the largest and most influential academic events in global oncology, the ASCO meeting brought together numerous world-class oncology experts. It focused on the unmet clinical needs in gastrointestinal malignancies such as hepatocellular carcinoma, cholangiocarcinoma, and pancreatic cancer, and presented a wealth of cutting-edge research findings and therapeutic innovations. These advances provide important evidence-based support for the diagnosis and treatment of hepatobiliary and pancreatic cancers. Based on the latest achievements presented at ASCO 2025, this article discusses the hot topics and future directions in the management of hepatobiliary and pancreatic tumors.